Page last updated: 2024-11-03

promazine and Parkinson Disease

promazine has been researched along with Parkinson Disease in 2 studies

Promazine: A phenothiazine with actions similar to CHLORPROMAZINE but with less antipsychotic activity. It is primarily used in short-term treatment of disturbed behavior and as an antiemetic.
promazine : A phenothiazine deriative in which the phenothiazine tricycle has a 3-(dimethylaminopropyl) group at the N-10 position.

Parkinson Disease: A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75)

Research Excerpts

ExcerptRelevanceReference
"(ii) The effect of schizophrenia is to increase MAE duration, and this is not due to some peripheral artefact."2.39The duration of the movement aftereffect as an index of psychiatric illness. ( Harris, J, 1994)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Scoyni, RM1
Aiello, L1
Trani, I1
Felli, B1
Masin, AM1
Camponi, V1
Dignazio, L1
Cortese, M1
Pacitti, MT1
Carratelli, D1
Morocutti, C1
Harris, J1

Reviews

1 review available for promazine and Parkinson Disease

ArticleYear
The duration of the movement aftereffect as an index of psychiatric illness.
    Perception, 1994, Volume: 23, Issue:10

    Topics: Adult; Antiparkinson Agents; Attention; Chlorpromazine; Dopamine; Eye Movements; Female; Fixation, O

1994

Other Studies

1 other study available for promazine and Parkinson Disease

ArticleYear
Drug adverse events and drop-out risk: a clinical case.
    Archives of gerontology and geriatrics, 2007, Volume: 44 Suppl 1

    Topics: Aged, 80 and over; Alzheimer Disease; Antipsychotic Agents; Benzothiazoles; Brain; Dopamine Agonists

2007